(AIS, CRWE, ARWR, SPPI) CRWENewsAlert.com Stock Report
Arrowhead Research Corp showed an Odd Volume - NASDAQ:ARWR
Strange Volume of Arrowhead Research Corp - NASDAQ:ARWR
Arrowhead Research Corp (NASDAQ:ARWR) witnessed volume of 5.82 million shares during last trade however it holds an average trading capacity of 204,257 shares. ARWR last trade opened at $0.80 reached intraday low of $0.70 and went +40.19% up to close at $0.75.
Read Full Article and Disclaimer at:http://stockbling.com/8029/business-news/strange-volume-of-arrowhead-res...
FTK, Flotek Industries Inc.
** On its third quarter fiscal 2011, FTK posted revenue of $75.1 million, an 87.7% increase year over year and net income attributable to common stockholders of $17.9 million, or $0.38 per common share (basic), compared to a net loss of $2.4 million, or ($0.09) per common share for the same period in 2010.
NHPR.OB, ARWR, MTEX, SIRI, - CRWESelect.com Stock Report! National Health Partners, Arrowhead Research Corp., Mannatech Inc.
HOLL, ARWR, PPWE.OB, ULGX, ORFG.PK, - CRWESelect.com Stock Report! Hollywood Media Corp., Arrowhead Research Corp., Proper Power
Hollywood Media Corp. (NASDAQ:HOLL) announced that it has commenced a tender offer to purchase up to 9,000,000 shares of its common stock at a price of $2.00 per share, less any applicable withholding taxes and without interest. The number of shares proposed to be purchased in the tender offer represents approximately 28.9% of the 31,179,066 shares of Hollywood Media Corp.
PPWE.OB, ARWR, APPY, IMOS - Stock Market Watch & News From PennyToBuck.com
(BX, ROSG, ARWR, ORFG, HSKA) PennyOmega.com Stocks in Action
bx BX, The Blackstone Group, L.P.
BX, together with its subsidiaries, provides alternative asset management and financial advisory services worldwide. BX operates in four segments: Private Equity, Real Estate, Credit and Marketable Alternatives, and Financial Advisory.
AUTH, ASTC, ARWR, GRHU, BOB.V - Market Update From DrStockPick.com!
ARWR, CRWE.OB, HURN, IFF, - Arrowhead Research, Crown Equity Holdings, Huron Consulting and International Flavors & Fragrances
Arrowhead Research Corporation (NASDAQ:ARWR) previously reported that its portfolio companies, Calando Pharmaceuticals, Inc. and Nanotope, Inc., have been awarded cash grants totaling $490,000 ($245,000 each) under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) program.